| Title: | Phenome of coeliac disease vs. inflammatory bowel disease |
| Journal: | Scientific Reports |
| Published: | 26 Aug 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36028550/ |
| DOI: | https://doi.org/10.1038/s41598-022-18593-y |
| URL: | https://www.nature.com/articles/s41598-022-18593-y.pdf |
| Citations: | 6 (6 in last 2 years) as of 8 Aug 2024 |
Publication 10457
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Coeliac disease (CeD) is characterized by gliadin-induced intestinal inflammation appearing in genetically susceptible individuals, such as HLA-DQ2.5 carriers. CeD, as well as other chronic intestinal disorders, such as Crohn's disease (CD) and ulcerative colitis, has been associated with increased morbidity and mortality, but the causes are unknown. We systematically analysed CeD-associated diagnoses and compared them to conditions enriched in subjects with CD/UC as well as in HLA-DQ2.5 carriers without CeD. We compared the overall and cause-specific mortality and morbidity of 3,001 patients with CeD, 2,020 with CD, 4,399 with UC and 492,200 controls in the community-based UK Biobank. Disease-specific phenotypes were assessed with the multivariable Phenome Wide Association Study (PheWAS) method. Associations were adjusted for age, sex and body mass index. All disease groups displayed higher overall mortality than controls (CD: aHR = 1.91[1.70-2.17]; UC: aHR = 1.32 [1.20-1.46]; CeD: aHR = 1.38 [1.22-1.55]). Cardiovascular and cancer-related deaths were responsible for the majority of fatalities. PheWAS analysis revealed 166 Phecodes overrepresented in all three disorders, whereas only ~ 20% of enriched Phecodes were disease specific. Seven of the 58 identified CeD-specific Phecodes were enriched in individuals homozygous for HLA-DQ2.5 without diagnosed CeD. Four out of these seven Phecodes and eight out of 19 HLA-DQ2.5 specific Phecodes were more common in homozygous HLA-DQ2.5 subjects with vs. without CeD, highlighting the interplay between genetics and diagnosis-related factors. Our study illustrates that the morbidity and mortality in CeD share similarities with CD/UC, while the CeD-restricted conditions might be driven by both inherited and acquired factors.</p>
4 Authors
- Moritz Kleinjans
- Carolin V. Schneider
- Tony Bruns
- Pavel Strnad
1 Application
| Application ID | Title |
|---|---|
| 47527 | Analysis of Alpha1-Antitrypsin related comorbidities |
Enabling scientific discoveries that improve human health